Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy

BACKGROUND: Diminished systemic serum butyrylcholinesterase (BChE), a biomarker for chronic inflammation, cachexia, and advanced tumor stage, has shown to play a prognostic role in various malignancies. The aim of this study was to investigate the prognostic value of pretherapeutic BChE levels in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gensthaler, Lisa, Jomrich, Gerd, Brugger, Jonas, Kollmann, Dagmar, Paireder, Matthias, Bologheanu, Milena, Horn, Alexander, Riegler, Franz M., Asari, Reza, Schoppmann, Sebastian F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244274/
https://www.ncbi.nlm.nih.gov/pubmed/37280384
http://dx.doi.org/10.1007/s00423-023-02938-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244274/
https://www.ncbi.nlm.nih.gov/pubmed/37280384
http://dx.doi.org/10.1007/s00423-023-02938-w

Ejemplares similares